Post-approval studies (Phase 4)Study completedNCT03050229
What this trial is testing
SGLT-2i and ARB Combination Therapy in Patients With T2DM and Nocturnal Hypertension (SACRA Study)
Who this might be right for
Nocturnal HypertensionT2DM (Type 2 Diabetes Mellitus)
Jichi Medical University 174